Celldex Therapeutics buy Morgan Stanley
Start price
09.05.25
/
50%
€16.30
Target price
09.05.26
€38.34
Performance (%)
74.29%
End price
10.05.26
€28.41
Summary
This prediction ended on 10.05.26 with a price of €28.41. With a performance of 74.29% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | -8.863% | -8.863% | 59.895% |
| iShares Core DAX® | 0.073% | 0.242% | 2.887% |
| iShares Nasdaq 100 | -1.344% | -3.371% | 29.208% |
| iShares Nikkei 225® | -2.314% | -7.496% | 56.323% |
| iShares S&P 500 | -0.340% | 0.899% | 23.175% |
Comments by Morgan_Stanley for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its price target lowered by analysts at Morgan Stanley from $46.00 to $43.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Celldex Therapeutics
Stopped prediction by Morgan_Stanley for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.03.25
20.03.25
€42.18
20.03.26
20.03.26
42.39%
21.03.26
21.03.26
